LOC105370204: A Potential Drug Target and Biomarker (G105370204)

LOC105370204: A Potential Drug Target and Biomarker

Introduction

LOC105370204 is a gene that encodes a protein known as LOC105370204 (also known as X2). The protein is a key regulator of cell division and has been implicated in various diseases, including cancer. LOC105370204 has also been identified as a potential drug target and biomarker . In this article, we will explore the biology of LOC105370204 and its potential as a drug target and biomarker.

Biology of LOC105370204

LOC105370204 is a 21-kDa protein that is expressed in various tissues, including muscle, heart, brain, and organs. The protein has a unique structure that consists of a N-terminal transmembrane domain, a catalytic domain, and a C -terminal T-loop region. The N-terminal transmembrane domain is responsible for the protein's ability to interact with various cell signaling pathways, while the catalytic domain is responsible for the protein's catalytic activity. The C-terminal T -loop region is involved in the regulation of protein stability and can modulate the protein's half-life.

In addition to its unique structure, LOC105370204 has been shown to play a critical role in various cellular processes. For example, LOC105370204 has been shown to regulate cell division, cell migration, and cell survival. LOC105370204 has also been shown to play a role in the regulation of ion channels, which are critical for the flow of electrical current through cells.

Potential Drug Target

LOC105370204 has been identified as a potential drug target due to its unique structure and its involvement in various cellular processes. One of the most promising strategies for targeting LOC105370204 is to use small molecules that can modulate its activity. This approach is based on the idea that By binding to a specific protein, small molecules can alter its activity and ultimately disrupt its function.

One of the most promising small molecules that can bind to LOC105370204 is known as S132297, which is a inhibitor of the protein kinase (PK) kinase A. S132297 has been shown to inhibit the activity of PKA and to reduce the phosphorylation of various cellular signaling pathways, including the PI3K/Akt pathway. This suggests that S132297 could be an effective drug against LOC105370204.

Biomarker

LOC105370204 has also been identified as a potential biomarker for various diseases, including cancer. The protein has been shown to be highly expressed in various cancer tissues and has been used as a biomarker for various types of cancer, including breast, ovarian, and colorectal cancers. In addition, LOC105370204 has been shown to be involved in the regulation of cell division, which is a critical factor in the development and progression of cancer. This suggests that LOC105370204 could be an effective biomarker for the early detection and treatment of cancer.

Conclusion

LOC105370204 is a gene that encodes a protein with unique structure and function. The protein has been shown to play a critical role in various cellular processes, including cell division, cell migration, and cell survival. In addition, LOC105370204 has been identified as a potential drug target due to its unique structure and its involvement in various cellular processes. The protein has also been shown to be a potential biomarker for the early detection and treatment of cancer. Further research is needed to fully understand the biology of LOC105370204 and its potential as a drug target and biomarker.

Protein Name: Uncharacterized LOC105370204

The "LOC105370204 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105370204 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105370214 | LOC105370222 | LOC105370243 | LOC105370259 | LOC105370262 | LOC105370273 | LOC105370275 | LOC105370286 | LOC105370302 | LOC105370311 | LOC105370312 | LOC105370321 | LOC105370324 | LOC105370328 | LOC105370355 | LOC105370359 | LOC105370384 | LOC105370399 | LOC105370420 | LOC105370429 | LOC105370438 | LOC105370452 | LOC105370455 | LOC105370470 | LOC105370476 | LOC105370481 | LOC105370497 | LOC105370500 | LOC105370504 | LOC105370507 | LOC105370519 | LOC105370529 | LOC105370536 | LOC105370544 | LOC105370546 | LOC105370547 | LOC105370548 | LOC105370549 | LOC105370557 | LOC105370572 | LOC105370574 | LOC105370575 | LOC105370577 | LOC105370579 | LOC105370582 | LOC105370614 | LOC105370616 | LOC105370617 | LOC105370619 | LOC105370627 | LOC105370645 | LOC105370660 | LOC105370706 | LOC105370721 | LOC105370740 | LOC105370819 | LOC105370826 | LOC105370832 | LOC105370834 | LOC105370841 | LOC105370842 | LOC105370843 | LOC105370844 | LOC105370845 | LOC105370846 | LOC105370852 | LOC105370878 | LOC105370891 | LOC105370892 | LOC105370905 | LOC105370906 | LOC105370913 | LOC105370914 | LOC105370941 | LOC105370955 | LOC105370965 | LOC105370978 | LOC105370980 | LOC105370982 | LOC105370988 | LOC105370991 | LOC105370995 | LOC105371002 | LOC105371006 | LOC105371060 | LOC105371061 | LOC105371068 | LOC105371069 | LOC105371072 | LOC105371081 | LOC105371082 | LOC105371097 | LOC105371114 | LOC105371116 | LOC105371160 | LOC105371164 | LOC105371230 | LOC105371268 | LOC105371269 | LOC105371274